BioSpace News Archive

VisionHealth closes financing of 1 million Euro for certified health app Kata® in the field of inhalation therapy

Garching, 8th of April 2020 - VisionHealth GmbH, a pioneer for digital therapy support in inhalation therapy, announces the successful closing of a financing of 1 million Euro for market launch and future growth.

April 10, 2020
·
4 min read
Biotech Bay

Companies Taking Very Different Approaches to ACE2-Focused COVID-19 Therapies

At least three different biotech companies are working on two ACE2-related drugs to find a solution to the COVID-19 pandemic.

April 10, 2020
·
3 min read
·
Mark Terry
BioCapital

Clinical Catch-Up: April 6-10

It was a very busy week for clinical trial news. Here’s a look.

April 10, 2020
·
12 min read
·
Mark Terry
Study Shows Cancer Therapy Drug Could Stop or Reverse Damage to Kidneys Caused by Lupus Nephritis

A new study shows a cancer therapy drug may reverse the effects of lupus nephritis in patients with systemic lupus erythematosus (SLE, or lupus), an autoimmune disease.

April 10, 2020
·
1 min read
·
Michelle Brugioni
Drug Development

China’s CanSino Prepares to Advance COVID-19 Vaccine Candidate into Phase II

China’s CanSino Biologics is advancing its COVID-19 vaccine candidate into Phase II, putting the company ahead of others in the race against the novel coronavirus.

April 10, 2020
·
2 min read
·
Alex Keown
Drug Development

Biopharma Update on the Novel Coronavirus: April 10

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.

April 10, 2020
·
7 min read
·
BioSpace Editorial Staff
Business

AMA Doubles Down Against Off-Label Prescriptions, Despite Promising Evidence

On Thursday, the American Medical Association doubled down on its stance against using off-label medicines like hydroxychloroquine and chloroquine to treat COVID-19 patients.

April 10, 2020
·
5 min read
·
Gail Dutton
Drug Development

COVID-19 Continues to Impact Enrollment and Recruitment of Clinical Trial Patients

As COVID-19 has swept across the world, companies have had to make significant adjustments to the way business is conducted in a global economy. It has impacted all types of operations, including clinical trials.

April 10, 2020
·
4 min read
·
Alex Keown
Genetown

Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

The goal is to connect trial sites, sponsors and clinical research organizations to speed COVID-19 clinical trials for vaccines, drugs and diagnostics.

April 10, 2020
·
3 min read
·
Mark Terry
Business

AES Controls Creates a Ventilator Solution; Leverages CEO Connection Community to Launch and Scale

CEO Connection member CEO, Rick Salerno of AES Controls announces a solution to the ventilator shortage that will help save lives:

April 10, 2020
·
2 min read